Sortilin may hold the key to combat pancreatic cancer more effectively – Science Codex

Philadelphia, August 20, 2020 – Pancreatic cancer has an extremely poor prognosis; it is the third most common cause of cancer deaths in the United States. In a novel study published in TheAmerican Journal of Pathology, published by Elsevier, scientists report the discovery of an increased level of the neuroprotein sortilin in pancreatic cancer cells that may open up the way to developing more effective treatment.
“There is currently no good therapy for pancreatic cancer,” explained lead invest…

Click here to view the original article.